TY - JOUR T1 - Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19 JF - medRxiv DO - 10.1101/2021.02.09.21251371 SP - 2021.02.09.21251371 AU - Barak Mizrahi AU - Maytal Bivas-Benita AU - Nir Kalkstein AU - Pinchas Akiva AU - Chen Yanover AU - Yoav Yehezkelli AU - Yoav Kessler AU - Sharon Hermoni Alon AU - Eitan Rubin AU - Gabriel Chodick Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251371.abstract N2 - Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2-7 days after a SARS-CoV-2 positive test could identify patients at risk for severe illness. Analysis of a nationwide electronic health records data of 1,683 SARS-CoV-2 positive individuals indicated that a second negative PCR test result was associated with lower risk for severe illness compared to a positive result. This association was seen across different age groups and clinical settings. More importantly, it was not limited to recovering patients but also observed in patients who still had evidence of COVID-19 as determined by a subsequent positive PCR test. Our study suggests that an early second PCR test may be used as an additional risk-assessment tool to improve disease management and patient care.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by Maccabi Health Services institutional review board 0024-20-MHS. Informed consent was waived by the IRB, as all identifying details of the participants were removed before the computational analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study originate from Maccabi Health Services. Restrictions apply to the availability of these data and they are therefore not publicly available. Due to restrictions, these data can be accessed only by request to the authors and/or Maccabi Health Services. ER -